Inventor · disambiguated record
Uwe Reusch
Also filed as: REUSCH UWE
19 granted patents·10 pending applications·169 citations·filing 2002–2024
93Inventor score
Files withAFFIMED GMBH16AMPHIVENA THERAPEUTICS INC4AFFIMED THERAPEUTICS AG3HOFFMANN KARIN1LE GALL FABRICE1
Top patents by PatentIndex Score
29 records- 0192US9226962B2Human CD3-specific antibody with immunosuppressive propertiesAFFIMED THERAPEUTICS AG·Filed 2013·Granted Jan 5, 2016·38 cites·6 claims
- 0292US9212225B1Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Dec 15, 2015·17 cites·14 claims
- 0392US9035026B2Anti-CD16 binding moleculesHOFFMANN KARIN·Filed 2006·Granted May 19, 2015·54 cites·21 claims
- 0490US9803029B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·11 cites·18 claims
- 0589US9701750B2Anti-CD16 binding moleculesAFFIMED GMBH·Filed 2015·Granted Jul 11, 2017·11 cites·16 claims
- 0688US10626190B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·3 cites·12 claims
- 0787US11535672B2Combination of an anti-CD16A antibody with a cytokineAFFIMED GMBH·Filed 2019·Granted Dec 27, 2022·8 cites·28 claims
- 0885US10066015B2CD3 binding domainsAFFIMED GMBH·Filed 2015·Granted Sep 4, 2018·10 cites·11 claims
- 0982US11510972B2Bispecific EGFR/CD16 antigen-binding proteinAFFIMED GMBH·Filed 2020·Granted Nov 29, 2022·1 cites·16 claims
- 1079US11001633B2NK cell engaging antibody fusion constructsAFFIMED GMBH·Filed 2019·Granted May 11, 2021·1 cites·14 claims
- 1178US2024294647A1Uses of nk cell engaging antibody fusion constructs for treatmentsAFFIMED GMBH·Filed 2024·Application pending·0 cites
- 1274US10273309B2Antibody binding sites specific for EGFRvIIIAFFIMED GMBH·Filed 2016·Granted Apr 30, 2019·2 cites·21 claims
- 1373US12076384B2Bispecific EGFR/CD16 antigen-binding proteinAFFIMED GMBH·Filed 2022·Granted Sep 3, 2024·0 cites·17 claims
- 1471US7507797B2Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereofAFFIMED THERAPEUTICS AG·Filed 2004·Granted Mar 24, 2009·11 cites·14 claims
- 1569US7901677B1Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer typesAFFIMED THERAPEUTICS AG·Filed 2006·Granted Mar 8, 2011·1 cites·13 claims
- 1666US2021253698A1Uses of nk cell engaging antibody fusion constructs for treatmentsAFFIMED GMBH·Filed 2021·Application pending·0 cites
- 1765US12264198B2Tandem diabody for CD16A-directed NK-cell engagementAFFIMED GMBH·Filed 2021·Granted Apr 1, 2025·0 cites·11 claims
- 1865US2021024654A1Bispecific CD33 and CD3 Binding ProteinsAMPHIVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1961US9365647B2Compounds for use in the treatment of Alzheimer's diseaseWEISS STEFAN FRANZ THOMAS·Filed 2012·Granted Jun 14, 2016·1 cites·4 claims
- 2060US11180558B2Tandem diabody for CD16A-directed NK-cell engagementAFFIMED GMBH·Filed 2019·Granted Nov 23, 2021·0 cites·11 claims
- 2156US2022048994A1Trifunctional antigen-binding moleculeLITTLE MELVYN·Filed 2021·Application pending·0 cites
- 2253US2023365709A1Trispecific bindersAFFIMED GMBH·Filed 2021·Application pending·0 cites
- 2353US2006233787A1Human cd3-specific antibody with immunosuppressive propertiesLE GALL FABRICE·Filed 2003·Application pending·0 cites
- 2452US2021169936A1Cryopreserved NK cells preloaded with an antibody constructAFFIMED GMBH·Filed 2021·Application pending·0 cites
- 2547US2005079170A1Dimeric and multimeric antigen binding structureFiled 2002·Application pending·0 cites
- 2646US2016361413A1Compounds for use in the treatment of alzheimer's diseaseUNIV JOHANNESBURG WITWATERSRAND·Filed 2016·Application pending·0 cites
- 2744US11572415B2Multivalent FV antibodiesAFFIMED GMBH·Filed 2018·Granted Feb 7, 2023·0 cites·25 claims
- 2842US2017037128A1Trifunctional antigen-binding moleculeAFFIMED GMBH·Filed 2016·Application pending·0 cites
- 2941US11167029B2Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapyAFFIMED GMBH·Filed 2017·Granted Nov 9, 2021·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Uwe Reusch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →